In patients with COPD, elevated lung levels of miR-155 could contribute to inflammation by inducing the expression of MMP12 and ADAM19, which are proteases that cleave extracellular matrix proteins and release cytokines, such as TNFα [43]. This evidence concerns the gene ADAM19 and chronic obstructive pulmonary disease.